The US FTC finds a consummated merger between two sellers of prosthetic knees anticompetitive and orders assets to be divested (Otto Bock / Freedom)

This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards.

On November 6, 2019, the Federal Trade Commission unanimously found that the consummated merger of two sellers of prosthetic knees violated United States antitrust law, ordering the purchaser to divest completely the acquired assets to an FTC-approved buyer. The case is notable because the transaction was not reportable under the Hart-Scott-Rodino (“HSR”) Act, but the FTC nevertheless reviewed the deal subsequent to closing and found it to be anticompetitive. The Commission’s decision serves as another reminder that the antitrust agencies have the authority to review transactions that are not subject to filing under the HSR Act and that the buyer can be subject to post-closing remedies including complete divestiture. The HSR Act’s Reporting Requirements The HSR Act requires that parties

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.